SYROS PHARMACEUTICALS, INC. Operating Lease, Liability, Noncurrent
SYROS PHARMACEUTICALS, INC. had Operating Lease, Liability, Noncurrent of $16.56 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2024-10-31
- 2024-09-30: Operating Lease, Liability, Noncurrent $16.56M.
- 2024-06-30: Operating Lease, Liability, Noncurrent $17.23M.
- 2024-03-31: Operating Lease, Liability, Noncurrent $17.89M.
- 2023-12-31: Operating Lease, Liability, Noncurrent $18.53M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2024-09-30 | $16.56M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $17.23M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $17.89M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $18.53M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $19.14M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $19.73M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $20.30M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $20.85M 10-K · filed 2024-03-27 |
| 2022-09-30 | $21.39M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $21.89M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $22.38M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $22.86M 10-K · filed 2023-03-02 |
| 2021-09-30 | $23.32M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $23.75M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $24.17M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $24.58M 10-K · filed 2022-03-15 |
| 2020-09-30 | $24.97M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $25.34M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $24.24M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $24.02M 10-K · filed 2021-03-04 |
| 2019-09-30 | $18.43M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $16.25M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $765.00K 10-Q · filed 2019-05-01 |
| 2019-01-01 | $100.00K 10-Q · filed 2019-11-12 |